CB213 cross-species target affinities

CE Carolyn J. Edwards
AS Angelica Sette
CC Carl Cox
BF Barbara Di Fiore
CW Chris Wyre
DS Daniela Sydoruk
DY David Yadin
PH Philip Hayes
SS Szymon Stelter
PB Phillip D. Bartlett
MZ Miren Zuazo
MG Maria Jesus Garcia-Granda
GB Giovanni Benedetti
SF Stratoniki Fiaska
NB Neil R. Birkett
YT Yumin Teng
CE Carrie Enever
HA Hugo Arasanz
AB Ana Bocanegra
LC Luisa Chocarro
GF Gonzalo Fernandez
RV Ruth Vera
BA Bethan Archer
IO Isabelle Osuch
ML Martyna Lewandowska
YS Yasmin M. Surani
GK Grazyna Kochan
DE David Escors
JL James Legg
AP Andrew J. Pierce
request Request a Protocol
ask Ask a question
Favorite

A FortéBio OCTET instrument was used to study the interaction between CB213 with human (R&D Systems 2319-L3) and recombinant cynomolgus monkey LAG3-Fc tagged proteins (R&D System, 8578-PD-050) and similarly for recombinant human and cynomolgus monkey Fc-tagged PD1 (R&D Systems: 1086-PD, 8578-PD-050), and for albumin from human (Sigma Aldrich A3782), cynomolgus monkey (Abcam ab184894) and mouse (Sigma Aldrich A3559). Murine his-tagged LAG3 (Acro Biosystems LA3-M52H5) and recombinant mouse-PD1-human-Fc chimaera (R&D Systems, 1021-PD-100) proteins were also assessed, as was IgG from human serum (Sigma Aldrich I2511).

Targets in sodium acetate pH 6.0 were coupled to AR2G biosensors by amine coupling using the amine reagent coupling kit (2nd generation, FortéBio). Binding was then analysed against CB213 at a range of predetermined concentrations (7-point 2-fold dilution series in 1× dPBS + 0.02% Tween + 0.1% BSA, with a top concentration of 250 nM) with an association phase of 200 seconds and a dissociation phase of 300 seconds. The kinetics and affinities of the binding interactions were modelled using a 1:1 binding model and calculated using the FortéBio Analysis Software version 8.1 or above.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A